(Q42503484)

1 November 2017

title

Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer (English)

1 reference

randomized controlled trial

1 November 2017

main subject

1 reference

1 reference

S B Campbell

1

1 reference

1 November 2017

R Walker

2

1 reference

1 November 2017

S See Tai

3

1 reference

1 November 2017

Q Jiang

4

1 reference

1 November 2017

G R Russ

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

15 March 2012

1 reference

American Journal of Transplantation

1 November 2017

published in

1 reference

1 November 2017

volume

12

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

1146-1156

1 reference

Cancer incidence after immunosuppressive treatment following kidney transplantation

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Skin cancers after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Non-melanoma skin cancer risk in the Queensland renal transplant population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Post-transplant de novo malignancies in renal transplant recipients: the past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Skin cancer in organ transplant recipients--where do we stand today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Guidelines for the management of squamous cell carcinoma in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

The mTOR pathway: a new target in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Rapamycin: an anti-cancer immunosuppressant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Skin cancer in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04004.X

10.1111/J.1600-6143.2012.04004.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference